Catalyst Wire Dossier Catalyst Wire Dossier

Temferon

temferon · Genenta Science
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Temferon, covering 2022-01-28 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]

See pricing